Virtu KCG Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-40,300
Closed -$4.14M 3242
2015
Q4
$4.14M Buy
40,300
+2,700
+7% +$272K 0.07% 181
2015
Q3
$3.51M Buy
37,600
+11,100
+42% +$1.07M 0.06% 221
2015
Q2
$2.58M Sell
26,500
-10,800
-29% -$1.08M 0.05% 339
2015
Q1
$3.75M Buy
37,300
+2,900
+8% +$295K 0.08% 173
2014
Q4
$3.6M Sell
34,400
-26,400
-43% -$2.78M 0.06% 217
2014
Q3
$6.48M Buy
60,800
+10,200
+20% +$1.06M 0.13% 97
2014
Q2
$5.29M Sell
50,600
-20,300
-29% -$2.05M 0.08% 160
2014
Q1
$6.96M Sell
70,900
-23,300
-25% -$2.16M 0.09% 177
2013
Q4
$8.63M Buy
94,200
+6,200
+7% +$571K 0.1% 104
2013
Q3
$7.63M Buy
+88,000
New +$7.89M 0.1% 134

Other funds holding JNJ

Virtu KCG Holdings's JNJ Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Johnson & Johnson (JNJ) stake by 21% in Q2 2017, selling an estimated $1.03M and leaving 29,997 shares worth $3.97M. The position accounts for 0.11% of the portfolio, ranked #90.

Virtu KCG Holdings first reported a position in JNJ in Q3 2013 and has held it in 16 quarters since. The position peaked at $11.9M in Q4 2015. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Virtu KCG Holdings held 29,997 shares of Johnson & Johnson worth $3.97M as of Q2 2017.
  • Virtu KCG Holdings sold 8,040 Johnson & Johnson shares in Q2 2017, an estimated $1.03M.
  • Johnson & Johnson made up 0.11% of Virtu KCG Holdings's portfolio in Q2 2017, its #90 holding.
  • Virtu KCG Holdings first reported a position in Johnson & Johnson in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Johnson & Johnson position peaked at $11.9M in Q4 2015.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.